Buprenorphine And Naloxone Film
Product Images NDC 67296-2228

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-2228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn12mg (Ctn12mg)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 12 mg/3 mg strength. The label indicates the medication is for prescription use only and comes in a package containing 30 pouches with one sublingual film each. It includes manufacturer information for Ingenus Pharmaceuticals, LLC, storage instructions, and dosing directions for buccal and sublingual administration.*

FDA Label Image

Ctn2mg (Ctn2mg)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg strength. The label indicates it contains 30 pouches, each with one sublingual film. It includes usage warnings, storage instructions, and manufacturer information for Ingenus Pharmaceuticals, LLC. The label states 'Rx only' and contains a barcode and NDC 50742-397-30.*

FDA Label Image

Ctn4mg (Ctn4mg)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg. The label states it is prescription only and contains 30 pouches each with one sublingual film. The product is manufactured for Ingenus Pharmaceuticals, LLC. Instructions for administration and storage are also included on the label.*

FDA Label Image

Ctn8mg (Ctn8mg)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg strength. The label indicates the film is for sublingual administration, comes in a box of 30 pouches each containing 1 film, and is marked Rx only. Manufactured for Ingenus Pharmaceuticals, with storage and usage instructions included.*

FDA Label Image

Figure3.jpg (Figue3)

An instructional diagram showing a front view of an open mouth, focusing on the oral cavity, tongue, and teeth. Vertical guide lines indicate placement or positioning within the mouth, likely related to administration of the buccal or sublingual film dosage form.*

FDA Label Image

Figure1.jpg (Figure1)

An instructional illustration showing how to properly handle a buccal or sublingual film dosage form. The left panel depicts holding the film with both hands by the top corners, and the right panel shows the film being positioned similarly, presumably preparing for administration.*

FDA Label Image

Figure2.jpg (Figure2)

An instructional illustration showing hands manipulating a buccal or sublingual film dosage form. The left panel depicts peeling or opening of a sealed foil pouch, and the right panel shows placement of the film on the inside of the lower lip or cheek, demonstrating the administration route for buccal or sublingual films.*

FDA Label Image

Figure4.jpg (Figure4)

An instructional diagram showing the placement of a buprenorphine and naloxone sublingual film inside the mouth. The first panel depicts a hand positioning the rectangular film under the tongue, and the second panel shows the film resting under the tongue within an open mouth.*

FDA Label Image

Structurebuprenorpine.jpg (Structurebuprenorpine)

Chemical structure of buprenorphine, shown with an HCl (hydrochloride) annotation, as part of the drug Buprenorphine and Naloxone. The image depicts the molecular arrangement of atoms typical in chemical structural formulas.*

FDA Label Image

Structurenaloxone.jpg (Structurenaloxone)

Chemical structure diagram of buprenorphine, one of the active ingredients in the Buprenorphine and Naloxone film product. The structure includes labeled atoms and bonds, with a notation for hydrochloride dihydrate (HCl • 2H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.